Abstract:Protein phosphorylation is the most significant post-translational modification for regulating cellular activities, but site-specific modulation of phosphorylation is still challenging. Using three-dimensional NMR spectra, molecular dynamics simulations, and alanine mutations, we identified that the interaction network between pT69/pS70 and R106/R109 residues prevents the phosphorylation sites from exposure to phosphatase and subsequent dephosphorylation. A Bcl-2-dephosphorylation probe, S1-6e, was designed by installing a carboxylic acid group to a Bcl-2 inhibitor. The carboxyl group competitively disrupts the interaction network between R106/R109 and pT69/pS70 and subsequently facilitates Bcl-2 dephosphorylation in living cells. As a result, S1-6e manifests a more effective apoptosis induction in pBcl-2-dependent cancer cells than other inhibitors exhibiting a similar binding affinity for Bcl-2. We believe that targeting the allosteric pathways interconnecting the core-functional domain and the phosphorylation site can be a general strategy for a rational design of site-specific dephosphorylating probes, since the allosteric pathway has been discovered in a variety of proteins.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c01290?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01290</a>.List of (φ, ψ) backbone angle pairs for residues R106-D111, diagram of the phosphorylation sites of Bcl-2, 3D NMR titration spectra of different Bcl-2 variants, crystal structure of Bcl-2 isoform 2 in complex with ABT-263 or ABT-199 analogue, plot of the RMSD values of the backbone atoms in MD, binding affinity curves of BH3 peptides or compounds with different Bcl-2 variants, binding affinity curves of compounds with Bcl-xl and Mcl-1, and LC–MS spectra of the compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01290/suppl_file/jm0c01290_si_001.pdf">PDF</a>)MD-simulated structure of pBcl-2 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01290/suppl_file/jm0c01290_si_002.pdb">PDB</a>)Docking-stimulated structure of S1-6e/Bcl-2 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01290/suppl_file/jm0c01290_si_003.pdb">PDB</a>)Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01290/suppl_file/jm0c01290_si_004.csv">CSV</a>)This article has not yet been cited by other publications.

[Expression, Purification and Activity Analyses of Three Bcl-2 Family Proteins].

Experimental Characterization of the Binding Affinities Between Proapoptotic BH3 Peptides and Antiapoptotic Bcl-2 Proteins

A New Assay Based on Fluorescence Resonance Energy Transfer to Determine the Binding Affinity of Bcl-xLInhibitors

Design, Synthesis, And Interaction Study Of Quinazoline-2(1h)-Thione Derivatives As Novel Potential Bcl-X(L) Inhibitors

A Conserved Hydrophobic Core At Bcl-X(L) Mediates Its Structural Stability And Binding Affinity With Bh3-Domain Peptide Of Pro-Apoptotic Protein

Bcl-X(L) Forms Two Distinct Homodimers at Non-Ionic Detergents: Implications in the Dimerization of Bcl-2 Family Proteins

Characterization of the anti-apoptotic mechanism of Bcl-B

B-cell Lymphoma-2 Family Proteins in the Crosshairs: Small Molecule Inhibitors and Activators for Cancer Therapy.

Purification and characterization of the bcl-2 protein

Molecular Basis of Bcl-xL’s Target Recognition Versatility Revealed by the Structure of Bcl-xL in Complex with the BH3 Domain of Beclin-1

Computational Design of BH3-Mimetic Peptide Inhibitors That Can Bind Specifically to Mcl-1 or Bcl-XL: Role of Non-Hot Spot Residues

Polyubiquitination and proteasomal turnover controls the anti-apoptotic activity of Bcl-B

The Novel Small Molecular BH3 Mimetics SM3 and Its Regulation of Cell Apoptosis and Autophagy.

Characterizing the consensus residue specificity and surface of BCL-2 binding to BH3 ligands using the Knob-Socket model

Targeting the Allosteric Pathway That Interconnects the Core-Functional Scaffold and the Distal Phosphorylation Sites for Specific Dephosphorylation of Bcl-2

Peptide screening to knockdown Bcl-2's anti-apoptotic activity: implications in cancer treatment

Discovery and Development of Thiazolo[3,2-a]pyrimidinone Derivatives As General Inhibitors of Bcl-2 Family Proteins

Production,expression and purification of Bcr-Abl tyrosine kinase domain and its mutants

Abstract #3656: the BH3 Alpha Helical Mimic BH3M-6 Disrupts Bcl-xL/Bax and Mcl-1/Bax Binding and Induces Apoptosis in Human Cancer Cells in a Bcl-xL, Bcl2 and Mcl-1 Dependent Manner.

Structural Analysis of the Interaction between Bcl-xL and the Noncanonical BH3 Domain of Non-Bcl-2 Family Proteins

Development of Small Molecule Inhibitors on Bcl-2/BcI-XL Protein